EVH

4.32

1.41% 0.06

Dopo l'orario di chiusura: 4.32

Evolent Health Inc (EVH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché EVH Giù? Forum Previsione

Precedente Chiudi:

$4.26

Aprire:

$4.23

Volume 24 ore:

1.48M

Relative Volume:

0.49

Capitalizzazione di mercato:

$488.42M

Reddito:

$1.89B

Utile/perdita netta:

$-496.52M

Rapporto P/E:

-0.9076

EPS:

-4.7598

Flusso di cassa netto:

$1.40M

1 W Prestazione:

-6.09%

1M Prestazione:

+38.91%

6M Prestazione:

+21.69%

1 anno Prestazione:

-54.48%

Intervallo 1D:

$4.15

$4.345

Intervallo di 1 settimana:

$4.065

$4.535

Portata 52W:

$2.095

$10.08

Evolent Health Inc Stock (EVH) Company Profile

Nome

Evolent Health Inc

Settore

Healthcare (1074)

Industria

Health Information Services (47)

Telefono

571-389-6000

Indirizzo

1812 NORTH MOORE ST, SUITE 1705, ARLINGTON

Dipendente

4,200

Cinguettio

@EvolentHealth

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

EVH's Discussions on Twitter

Compare EVH vs VEEV, BTSG, TEM, TXG, HQY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EVH Evolent Health Inc	4.32	531.38M	1.89B	-496.52M	1.40M	-4.7598
VEEV Veeva Systems Inc	275.09	40.70B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	60.73	11.78B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	64.62	12.03B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	62.65	8.32B	638.78M	-22.66M	122.18M	-0.1744
HQY Healthequity Inc	96.07	8.72B	1.34B	230.70M	440.96M	2.6695

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2025-11-13	Iniziato	BMO Capital Markets	Outperform
2025-11-13	Aggiornamento	Stephens	Equal-Weight → Overweight
2025-01-10	Iniziato	Needham	Buy
2024-12-03	Reiterato	BTIG Research	Buy
2024-11-08	Downgrade	Stephens	Overweight → Equal-Weight
2024-10-11	Iniziato	KeyBanc Capital Markets	Overweight
2024-08-09	Aggiornamento	Truist	Hold → Buy
2024-04-22	Iniziato	Citigroup	Buy
2024-03-01	Iniziato	Oppenheimer	Outperform
2024-01-03	Iniziato	Barclays	Overweight
2023-12-06	Iniziato	JMP Securities	Mkt Outperform
2023-10-16	Iniziato	UBS	Buy
2023-04-12	Iniziato	Stephens	Overweight
2022-11-01	Iniziato	Truist	Hold
2022-07-29	Iniziato	RBC Capital Mkts	Outperform
2022-03-30	Iniziato	Guggenheim	Buy
2021-11-18	Aggiornamento	JP Morgan	Neutral → Overweight
2021-04-29	Ripresa	JP Morgan	Neutral
2021-01-07	Iniziato	BTIG Research	Buy
2020-07-06	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2020-06-05	Downgrade	Goldman	Buy → Neutral
2020-06-02	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2018-10-05	Ripresa	Leerink Partners	Outperform
2018-06-04	Iniziato	Piper Jaffray	Overweight
2018-04-24	Ripresa	JP Morgan	Neutral
2017-09-20	Iniziato	KeyBanc Capital Mkts	Overweight
2017-06-02	Iniziato	Robert W. Baird	Outperform
2017-03-14	Iniziato	Oppenheimer	Outperform
2017-01-13	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-10-28	Ripresa	JP Morgan	Overweight
2016-08-05	Reiterato	FBR Capital	Outperform
2016-07-26	Iniziato	Jefferies	Buy
2016-07-13	Reiterato	FBR Capital	Outperform
2016-03-29	Iniziato	FBR Capital	Outperform
2016-01-06	Iniziato	Canaccord Genuity	Buy
2015-06-30	Iniziato	Goldman	Buy
2015-06-30	Iniziato	JP Morgan	Overweight
2015-06-30	Iniziato	Leerink Partners	Outperform
2015-06-30	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Evolent Health Inc Borsa (EVH) Ultime notizie

Aug 30, 2026

EVH | Evolent Health, Inc Class FinancialsRevenue Breakdown - Quiver Quantitative

Aug 23, 2026

Aug 20, 2026

EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits

Aug 20, 2026

Aug 18, 2026

EVH Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus

Aug 18, 2026

Aug 17, 2026

EVH Maintained by TD Cowen -- Price Target Raised to $6.00 - GuruFocus

Aug 17, 2026

Aug 16, 2026

TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo

Aug 16, 2026

1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK

Aug 16, 2026

Aug 14, 2026

5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance

Aug 14, 2026

Aug 13, 2026

Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com

Aug 13, 2026

Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 13, 2026

Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang

Aug 13, 2026

Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha

Aug 13, 2026

Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail

Aug 13, 2026

Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com

Aug 13, 2026

Aug 12, 2026

EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus

Aug 12, 2026

Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com

Aug 12, 2026

Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks - Investing.com

Aug 12, 2026

Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com

Aug 12, 2026

Aug 11, 2026

Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com

Aug 11, 2026

EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus

Aug 11, 2026

EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget

Aug 11, 2026